Atria Investments’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.14M | Sell |
18,173
-11,499
| -39% | -$801K | 0.01% | 987 |
|
|
2025
Q4 | $1.97M | Buy |
29,672
+11,975
| +68% | +$774K | 0.02% | 727 |
|
|
2025
Q3 | $1.19M | Sell |
17,697
-2,833
| -14% | -$224K | 0.01% | 960 |
|
|
2025
Q2 | $1.79M | Buy |
20,530
+2,202
| +12% | +$173K | 0.02% | 771 |
|
|
2025
Q1 | $1.25M | Buy |
18,328
+949
| +5% | +$77.4K | 0.02% | 910 |
|
|
2024
Q4 | $1.35M | Buy |
17,379
+2,059
| +13% | +$152K | 0.02% | 840 |
|
|
2024
Q3 | $1.03M | Sell |
15,320
-11,000
| -42% | -$903K | 0.01% | 955 |
|
|
2024
Q2 | $2.98M | Buy |
26,320
+2,289
| +10% | +$289K | 0.04% | 502 |
|
|
2024
Q1 | $3.33M | Sell |
24,031
-386
| -2% | -$48.5K | 0.05% | 467 |
|
|
2023
Q4 | $3.03M | Sell |
24,417
-377
| -2% | -$38.5K | 0.05% | 446 |
|
|
2023
Q3 | $2.31M | Sell |
24,794
-4,378
| -15% | -$494K | 0.04% | 518 |
|
|
2023
Q2 | $3.75M | Buy |
29,172
+1,610
| +6% | +$195K | 0.07% | 344 |
|
|
2023
Q1 | $3.2M | Sell |
27,562
-3,992
| -13% | -$447K | 0.06% | 375 |
|
|
2022
Q4 | $3.57M | Sell |
31,554
-775
| -2% | -$85.1K | 0.07% | 338 |
|
|
2022
Q3 | $2.6M | Sell |
32,329
-766
| -2% | -$64.9K | 0.06% | 405 |
|
|
2022
Q2 | $2.47M | Sell |
33,095
-6,425
| -16% | -$586K | 0.05% | 428 |
|
|
2022
Q1 | $5.05M | Buy |
39,520
+4,044
| +11% | +$442K | 0.09% | 284 |
|
|
2021
Q4 | $4.76M | Buy |
35,476
+2,988
| +9% | +$429K | 0.08% | 291 |
|
|
2021
Q3 | $4.44M | Buy |
32,488
+5,320
| +20% | +$671K | 0.08% | 288 |
|
|
2021
Q2 | $2.9M | Buy |
27,168
+12,316
| +83% | +$1.18M | 0.06% | 381 |
|
|
2021
Q1 | $1.33M | Buy |
14,852
+2,508
| +20% | +$235K | 0.03% | 599 |
|
|
2020
Q4 | $1.14M | Sell |
12,344
-624
| -5% | -$55.7K | 0.03% | 629 |
|
|
2020
Q3 | $1.34M | Sell |
12,968
-44,168
| -77% | -$4.61M | 0.04% | 466 |
|
|
2020
Q2 | $5.79M | Buy |
+57,136
| New | +$5.11M | 0.2% | 126 |
|
|
2020
Q1 | – | Sell |
-13,416
| Closed | -$734K | – | 704 |
|
|
2019
Q4 | $734K | Buy |
13,416
+756
| +6% | +$35.9K | 0.02% | 654 |
|
|
2019
Q3 | $472K | Sell |
12,660
-640
| -5% | -$24.9K | 0.02% | 596 |
|
|
2019
Q2 | $511K | Buy |
13,300
+548
| +4% | +$17.2K | 0.02% | 572 |
|
|
2019
Q1 | $380K | Sell |
12,752
-604
| -5% | -$21.2K | 0.02% | 611 |
|
|
2018
Q4 | $400K | Buy |
13,356
+2,100
| +19% | +$66.6K | 0.02% | 574 |
|
|
2018
Q3 | $403K | Sell |
11,256
-1,176
| -9% | -$36.5K | 0.02% | 659 |
|
|
2018
Q2 | $295K | Sell |
12,432
-992
| -7% | -$21K | 0.01% | 746 |
|
|
2018
Q1 | $249K | Buy |
+13,424
| New | +$199K | 0.01% | 736 |
|
Other funds holding DXCM
VCM
VPM
Atria Investments's DXCM Position: Q1 2026 in Review
Atria Investments reduced its DexCom (DXCM) stake by 39% in Q1 2026, selling an estimated $801K and leaving 18,173 shares worth $1.14M. The position accounts for 0.01% of the portfolio, ranked #987.
Atria Investments first reported a position in DXCM in Q1 2018 and has held it in 32 quarters since. The position peaked at $5.79M in Q2 2020. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Atria Investments held 18,173 shares of DexCom worth $1.14M as of Q1 2026.
- Atria Investments sold 11,499 DexCom shares in Q1 2026, an estimated $801K.
- DexCom made up 0.01% of Atria Investments's portfolio in Q1 2026, its #987 holding.
- Atria Investments first reported a position in DexCom in Q1 2018 and has held it in 32 quarters since.
- Atria Investments's DexCom position peaked at $5.79M in Q2 2020.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.